%PDF-1.4
%
103 0 obj
<>
endobj
100 0 obj
<>
endobj
159 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-08-05T16:07:58Z
2024-03-29T04:29:01-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-29T04:29:01-07:00
application/pdf
Heather
2004-754.aug
uuid:f8894fb2-1dd1-11b2-0a00-650827bd7700
uuid:f8894fb4-1dd1-11b2-0a00-900000000000
endstream
endobj
89 0 obj
<>
endobj
90 0 obj
<>
endobj
104 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
35 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
58 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
66 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
69 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
189 0 obj
[193 0 R]
endobj
190 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
12 789 587 -785 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.02499 Tw 8 0 0 8 73.9 736.6941 Tm
(Prediction and treatment with cyclosporine. J Rheumatol)Tj
0 Tw 0 -1.25 TD
(1999;26:1527-33.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(20.)-875.1 (Maeda K, Kimura R, Komuta K, Igarashi )17.7 (T)73.9 (.)-0.1 ( Cyclosporine treatment)]TJ
2.175 -1.25 Td
(for polymyositis/dermatomyositis: Is it possible to rescue the )Tj
0 Tc T*
(deteriorating cases with interstitial pneumonitis? Scand )Tj
T*
(J Rheumatol 1997;26:24-9.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(21.)-875.1 (Miyake S, Ohtani )36.8 (Y)129.1 (, Sawada M, Inase N, Miyazaki )36.7 (Y)129.1 (,)-0.1 ( )17.7 (T)69.7 (akano S.)]TJ
2.175 -1.25 Td
[(Usefulness of cyclosporine )54.8 (A)-219.9 (on rapidly progressive interstitial)]TJ
0 Tc T*
[(pneumonia in dermatomyositis. Sarcoidosis )17.7 (V)111.1 (asc Dif)17.8 (fuse Lung Dis)]TJ
0 Tw T*
(2002;19:128-33.)Tj
0.0249 Tw 30.825 11.25 Td
[(22.)-875 (Nagasaka K, Harigai M, )17.7 (T)69.8 (ateishi M, et al. Ef)17.8 (ficacy of combined)]TJ
2.175 -1.25 Td
[(treatment with cyclosporine )54.8 (A)-219.8 (and corticosteroids for acute )]TJ
T*
(interstitial pneumonitis associated with dermatomyositis. Mod)Tj
T*
(Rheumatol 2003;13:231-8.)Tj
-2.175 -1.25 Td
[(23.)-875 (T)69.8 (akizawa H, Ito K. Cyclophosphamide pulse therapy for rapidly)]TJ
2.175 -1.25 Td
[(progressive interstitial pneumonia in dermatomyositis. )54.9 (A)-219.8 (new )]TJ
T*
(possibility for rescue? Intern Med 1997;36:448-9.)Tj
-2.175 -1.25 Td
[(24.)-875 (T)69.8 (anaka F)79.8 (, Origuchi )17.7 (T)74 (, Migita K, et al. Successful combined therapy)]TJ
2.175 -1.25 Td
(of cyclophosphamide and cyclosporine for acute exacerbated )Tj
T*
(interstitial pneumonia associated with dermatomyositis. Intern Med)Tj
0 Tw T*
(2000;39:428-30.)Tj
ET
/CS0 CS 0 0 0 1 SCN
53.46 77 m
558.47 77 l
S
0 0 0 0 scn
52.32 70.16 64.18 -15.66 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
8 0 0 8 53.3216 57.2343 Tm
(1726)Tj
ET
0 0 0 0 scn
355.5 70.16 203 -15.66 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
0.02499 Tw 8 0 0 8 423.8613 57.2343 Tm
(The Journal of Rheumatology 2005; 32:9)Tj
ET
0 0 0 0 scn
/GS0 gs
103.13 82.08 407.5 -10.83 re
f*
0.5 w
103.13 82.08 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
142 0 obj
<>
endobj
164 0 obj
<>
endobj
110 0 obj
<>
endobj
106 0 obj
<>
endobj
108 0 obj
<>
endobj
134 0 obj
<>stream
HVpMg}9ބ(ysHIn-ޗ䊮WpC= yo_=]JAaD~FsiY=_ s0}ϒ*,,̑oI{@Y
x]Paݦ}|~q߿dB:'iDD-m2$95ҭ$+;Tc}$PP.H0V}BBbV؎R]
8ʋPITd\EaaC>ZGouT[;@FFL(#7G|ab^Nc@˱ܩND#ÁhOWq -"d5^mp{1Vc#91UV(VS/~1
muX
![JhHF'Ɲfzf|8ઈ'w!qZzB٥hHbee6iD{2!O%#DgS-2Y>'K\yP~**u=DNVH|h-~ޭ'Gٙh=<pEd2wV\2Nr+I
U|V5/p/;sN/a*1Jv{){ge+;w{)7pqw "JpĊ$fybKEX&^{[GX\SR~"OKyMޔ?*Jb$uMkUNGC}BCSCcӊҬJk٪gWW2IgWGb4GOLG!J0Yjn`=71}g;ɮUf#!BBe<('&b(bxU,f8śr)q]w^MF6RLr|K{r4nyFJ*#J@T+[mv Qy!>.]gĴnղEdӡ7Tcp
?MaOۘ?l?me,=Mǖ"FkC^cfcx=*VSL+2.=toBin
5UkX͍4XҎl";4m5 otp
.40ӛÑMgfh} Vuc0ݟUd&L%P`o&7rW$e`r!8n_{Ok
KX{JX4kYԾa8jb,LP' T,hƧ@3l0]S-%Ѓ?m4o>- 4K)1?^~|`6ʹ4)fmPX˝Qiv0ctK<1P/uw얭`:j1.x2L5ibmM#cwӸ_X3"uL\[oi?SuqXok$%